Torthaí cuardaigh - Klumpp, Martin
- 1 - 4 toradh as 4 á dtaispeáint
-
1
-
2
Development and validation of a generic fluorescent methyltransferase activity assay based on the Transcreener(®) AMP/GMP Assay de réir Klink, Tony A., Staeben, Matt, Twesten, Kim, Kopp, Andrew L., Kumar, Meera, Dunn, Rebecca Schall, Pinchard, Cori A., Kleman-Leyer, Karen M., Klumpp, Martin, Lowery, Robert G.
Foilsithe / Cruthaithe 2011Téacs -
3
Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach de réir Chen, Chao, Zhu, Hugh, Stauffer, Frédéric, Caravatti, Giorgio, Vollmer, Susanne, Machauer, Rainer, Holzer, Philipp, Möbitz, Henrik, Scheufler, Clemens, Klumpp, Martin, Tiedt, Ralph, Beyer, Kim S., Calkins, Keith, Guthy, Daniel, Kiffe, Michael, Zhang, Jeff, Gaul, Christoph
Foilsithe / Cruthaithe 2016Téacs -
4
PIKfyve, a class III PI-kinase, is the target of the small molecular IL12/23 inhibitor apilimod and a new player in toll-like receptor signaling de réir Cai, Xinming, Xu, Yongyao, Cheung, Atwood K., Tomlinson, Ronald C., Alcázar-Román, Abel, Murphy, Leon, Billich, Andreas, Zhang, Bailin, Feng, Yan, Klumpp, Martin, Rondeau, Jean-Michel, Fazal, Aleem N., Wilson, Christopher J., Myer, Vic, Joberty, Gerard, Bouwmeester, Tewis, Labow, Mark A., Finan, Peter M., Porter, Jeffrey A., Ploegh, Hidde L., Baird, Daniel, De Camilli, Pietro, Tallarico, John A., Huang, Qian
Foilsithe / Cruthaithe 2013Téacs